Authors


Haroon Burhanullah, MD

Latest:

Elder Abuse and Ageism During COVID-19

The pandemic hit everyone hard, but what implications and consequences has it had for the older generations?


Trina Histon, PhD

Latest:

Delivering Health Care Through Digital Mental Health Ecosystems

Here’s how a digital mental health ecosystem can seamlessly connect and support all facets of mental health care.




Wilsa M.S. Charles Malveaux, MD, MA, FAPA

Latest:

Addressing Racial and Ethnic Disparities in Women’s Mental Health Care

"Systemic racism is insidious and ingrained in our daily experience. Women of color are doubly minoritized."


Melissa Bernstein

Latest:

LifeLines: Finding Light

Melissa Bernstein, founder of toy company Melissa & Doug, talks about accepting the self in totality and journeying inwards.


Robert A. Hauser, MD, MBA

Latest:

The New Treatment for Tardive Dyskinesia

Learn about the results of the recent study on deutetrabenazine and the ways it is helping patients with tardive dyskinesia.


Jessica R. Molinaro, MD

Latest:

5 Fast Facts for Addressing Distress & Depression in Cancer

Despite advances in clinical care for patients with cancer, distress and depression continue to haunt patients. These fast facts will help you better understand and care for patients with cancer.


Dean Wundrach

Latest:

Changing the Way Climate Change Psychiatry Is Researched: A Medical Student Perspective

A recent study serves as a model for future studies and lists several implications for the future of climate change psychiatric research.


Ruo-Gu Xiong

Latest:

Connections Between Food Additives and Psychiatric Disorders

What are the connections between what we eat and disorders such as anxiety and depression?


Kalpana Prasad, MD

Latest:

Diversity and Inclusion: A Daily Effort

Diversity and inclusion will not become a norm unless we make a daily effort.


Nathan Bryson, PhD

Latest:

RE104: A Novel, Fast-Acting Psychedelic for Postpartum Depression

Experts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.


Audrey Clare Farley, PhD

Latest:

Girls and Their Monsters, Part 3

Here’s what the historic case of the Genain quadruplets reveals about some deeper, uncomfortable truths about American society.


Robert Drury

Latest:

Sex, Drugs, and Psychosis: Reviewing Psychiatric Medications’ Taboo Side Effect

The sexual side effects of psychiatric medications are troubling enough that some patients consider treatment cessation. The authors review 5 strategies for managing sexual dysfunction.


Stephen Wisniewski, PhD

Latest:

Rejecting the Accusation of a Violated STAR*D Protocol

The original STAR*D authors refute claims of a violated protocol.


Steven P. Levine, MD

Latest:

Defining Treatment-Resistant Depression

Does treatment-resistant depression exist? These 2023 APA Annual Meeting panelists discuss definitions in this exclusive video.


Victor Tang, MD, MSc, FRCPC

Latest:

Rehabilitation Through Stimulation: Exploring Noninvasive Brain Stimulation for Substance Use Disorders

In this CME article, review the current treatment modalities for noninvasive brain stimulation in the treatment of substance use disorders, and to explore the potential for further expansion of indications.


John A. Renner Jr, MD

Latest:

Impact of Stigma for Patients With Dual Diagnosis

What is the clinician’s role in reversing stigma for better outcomes?


Eleanor Cursor

Latest:

The Reality of an Eating Disorder

A medical student's award-winning piece on her battles with an eating disorder.


Nancy Mannix, JD

Latest:

Telling Humanity’s Brain Story: Insights From Brain Capital

Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?


Mark Mullen, MD

Latest:

Zuranolone for the Treatment of Adults With Major Depressive Disorder

This randomized, placebo-controlled, phase 3 clinical trial showed that a 14-day treatment course of oral zuranolone 50 mg/day in MDD led to significantly greater improvements in depressive symptoms when compared with placebo.


Makoto Kawai, MD

Latest:

Recognizing and Addressing Psychiatric Implications of Sleep Disorders

What sleep disorders are common in older adults and what are the associated risk factors and correlates?


Emily Simpkin, RN

Latest:

Dual Diagnosis: Double the Stigma, Double the Trouble

Understanding the additive effects of stigma surrounding dual diagnosis with both substance use disorder and a mental illness.


Jesse M. Ehrenfeld, MD, MPH

Latest:

Challenges for Transgender Patients: Thoughts From the AMA President

Some clinicians are afraid to ask about gender and sexuality. Here's how this affects patient outcomes.



Omar Munoz, MD

Latest:

Psychiatrists’ Response to Human Trafficking: An Update

How to help individuals caught in human trafficking: person-centered, culturally humble, trauma-informed care.


Sara Mourani, MD

Latest:

My Life is Hell, Doc. Please Help Me!

Why are psychotherapeutic interventions crucial in the treatment of GAD and anxiety disorders in general?


Robin Cooper, MD, DFLAPA

Latest:

Reflecting on Our Values: A Look at Medical School Graduation Rituals

“We cannot use the rituals of graduation as a public demonstration of inequity.”


Iris Cohen, MSW

Latest:

The Effect of Mindfulness on Outcomes in Psychiatric Patients

How can mindfulness-based intervention be used as an effective treatment option for psychiatric patients?


Christopher D. Verrico, PhD

Latest:

Clinical Management of Cannabis Complications

The rapidly changing field of cannabinoids and their clinical implications poses a particular challenge in psychiatry.

© 2024 MJH Life Sciences

All rights reserved.